CS logo
small CS logo
Coastal Digestive Health

Maroochydore, Queensland, Australia
Gastroenterologist in Queensland
Unit 503/5 Emporio Pl, Maroochydore QLD 4558

About Coastal Digestive Health


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
5
Eli Lilly and Company
5
Galapagos NV
3
Pfizer
3
Arena Pharmaceuticals
2
Gilead Sciences
2
Lumen Bioscience, Inc.
1
Total Rows: 7

Clinical Trials at Coastal Digestive Health


During the past decade, Coastal Digestive Health conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 6 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years222266443344000000000011Started TrialsCompleted Trails20162017201820192020202102468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
2016-11-14
2020-03-31
Completed
1,351
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
2017-02-23
2026-09-01
Active, not recruiting
1,173
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
2017-03-17
2025-01-01
Enrolling by invitation
1,000
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-03-07
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2018-08-24
2029-12-27
Recruiting
1,200
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
2018-06-18
2024-03-19
Recruiting
1,281

Rows per page:

1–21 of 21

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Coastal Digestive Health" #1 sponsor was "Celgene" with 5 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Galapagos NV" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Digestive Health" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 5Celgene: 5Eli Lilly and Company: 5Eli Lilly and Company: 5Galapagos NV: 3Galapagos NV: 3Pfizer: 3Pfizer: 3Arena Pharmaceuticals: 2Arena Pharmaceuticals: 2Gilead Sciences: 2Gilead Sciences: 2Lumen Bioscience, Inc.: 1Lumen Bioscience, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsArena is a whollyowned subsidiary ofPfizer: 3Arena is a whollyowned subsidiary ofPfizer: 3Gilead Sciences: 3Gilead Sciences: 3Galapagos NV: 1Galapagos NV: 1

Clinical Trials Conditions at Coastal Digestive Health


According to Clinical.Site data, the most researched conditions in "Coastal Digestive Health" are "Ulcerative Colitis" (10 trials), "Crohn's Disease" (4 trials), "Crohn Disease" (3 trials), "Eosinophilic Esophagitis" (3 trials) and "C. Diff. Infections" (1 trials). Many other conditions were trialed in "Coastal Digestive Health" in a lesser frequency.

Clinical Trials Intervention Types at Coastal Digestive Health


Most popular intervention types in "Coastal Digestive Health" are "Drug" (20 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Etrasimod" (5 trials), "Filgotinib" (4 trials), "Mirikizumab" (4 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Coastal Digestive Health


The vast majority of trials in "Coastal Digestive Health" are 21 trials for "All" genders.

Clinical Trials Status at Coastal Digestive Health


Currently, there are NaN active trials in "Coastal Digestive Health". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Coastal Digestive Health, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Coastal Digestive Health, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 17Phase 3: 17Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 10Recruiting: 10Completed: 5Completed: 5Active, not recruiting: 4Active, not recruiting: 4Enrolling by invitation: 1Enrolling by invitation: 1Terminated: 1Terminated: 1